MMP-408

N/A

Report date: 2022/07/01 15:29:28

NME

Base Information

Drug NameMMP-408

Drug Alias NameMMP-408

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionMatrix metalloproteinase 12 inhibitors

TargetsMatrix metalloproteinase 12

Therapy Area/IndicationsPulmonary Disease, Chronic Obstructive

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesPfizer Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesPfizer Inc

Active IndicationsN/A

Inactive IndicationsPulmonary Disease, Chronic Obstructive

ATC CodeN/A